Compounds > 3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol
Page last updated: 2024-09-03

3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol and aspartic acid

3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol has been researched along with aspartic acid in 1 studies

Compound Research Comparison

Studies
(3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol)		Trials
(3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol)		Recent Studies (post-2010)
(3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol)		Studies
(aspartic acid)		Trials
(aspartic acid)		Recent Studies (post-2010) (aspartic acid)
11743223,0054174,018

Protein Interaction Comparison

ProteinTaxonomy3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol (IC50)aspartic acid (IC50)
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)1.638
Excitatory amino acid transporter 1Homo sapiens (human)90.1265
Excitatory amino acid transporter 2Homo sapiens (human)11
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)1.638
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)1.638
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)1.638
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)1.638
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)1.638
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)1.638

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
During, MJ; Janson, CG; Leone, P; McPhee, SJ1

Reviews

1 review(s) available for 3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol and aspartic acid

ArticleYear
Global CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan disease.
    Current opinion in molecular therapeutics, 1999, Volume: 1, Issue:4

    Topics: Acetates; Acetazolamide; Amidohydrolases; Animals; Aspartic Acid; Brain; Brain Edema; Calcium Compounds; Canavan Disease; Child; Child, Preschool; Cholesterol; Combined Modality Therapy; Cytomegalovirus; Dependovirus; DNA, Recombinant; Female; Fetal Diseases; Genetic Therapy; Genetic Vectors; Glycerophospholipids; Humans; Infant; Injections, Intraventricular; Liposomes; Male; Mitochondria; Nerve Tissue Proteins; Osmotic Pressure; Phosphatidylethanolamines; Prenatal Diagnosis; Primates; Promoter Regions, Genetic; Protamines; Rats

1999